Peripherally Inserted Central Catheter (PICC) devices play an important role in modern healthcare by providing vascular access for patients who require extended intravenous treatment. These flexible catheters are inserted through a peripheral vein, typically in the arm, and advanced until the tip reaches a central vein. They are used in clinical settings for administering prescribed medications, fluids, nutrients, and blood products, as well as for blood sampling. Growing requirements for prolonged treatment, particularly among patients receiving cancer care and management for other chronic conditions, are influencing demand for reliable vascular access solutions. Developments in catheter design, material technology, and infection-prevention practices are further shaping the industry's evolution.

A comprehensive market assessment by Markntel Advisor estimates that the Global Peripherally Inserted Central Catheter (PICC) Devices Market is projected to reach USD 1.61 billion by 2030, registering a CAGR of 7.89% during 2026–2030. Triple-lumen catheters represent the leading design segment, accounting for approximately 53% of the market, while hospitals contribute more than 50% of end-user demand. North America holds the largest regional share at approximately 47.25%. Published in October 2025, the 190-page Global PICC Devices Market Research Report and Forecast examines industry dynamics, product categories, design preferences, end-user demand, regional performance, and competitive developments.

Growing Requirements for Long-Term Vascular Access

PICC devices are used in healthcare environments where patients require intravenous access over an extended treatment period. They can support the administration of prescribed therapies, including certain chemotherapy medicines, antibiotics, and parenteral nutrition. Their use may reduce the need for repeated peripheral needle insertions when prolonged vascular access is clinically appropriate.

The increasing burden of chronic diseases is an important factor influencing demand. Cancer treatment, complex infections, and other conditions may involve extended treatment schedules and repeated intravenous administration. As healthcare institutions manage these requirements, they evaluate vascular access devices according to clinical suitability, catheter design, patient needs, and the ability of trained staff to maintain them safely.

Triple-Lumen Design Leads the Market

The triple-lumen category holds approximately 53% of the market, making it the leading segment by design. These catheters contain three separate channels that can support the administration of different prescribed therapies through a single access device. This functionality can be relevant in complex clinical environments, including intensive care units, oncology departments, and bone marrow transplant settings, where patients may require multiple intravenous treatments.

The broader design category also includes single-lumen and double-lumen PICCs. Each configuration serves different clinical requirements, and selection depends on factors such as the prescribed treatment, patient condition, duration of access, and healthcare professional assessment. Manufacturers are therefore focused on providing product options that address varied hospital requirements while maintaining catheter reliability and quality.

Hospitals Remain the Primary End Users

Hospitals account for more than 50% of the market, reflecting their role in managing complex treatments and patients requiring extended vascular access. They have specialised clinical departments, trained healthcare personnel, and infrastructure for catheter insertion, monitoring, and maintenance. Ambulatory surgical centres and other healthcare facilities also contribute to demand as vascular access services extend across different care settings.

The growing emphasis on infection prevention is influencing procurement and clinical management practices. The World Health Organization's 2026 guidance on preventing infections associated with central venous catheters covers insertion, maintenance, access, replacement, and removal practices. It highlights the importance of aseptic techniques, hand hygiene, staff training, and surveillance. These priorities reinforce the need for dependable products alongside appropriate clinical protocols.

Regional Performance and Industry Opportunities

North America represents approximately 47.25% of the global market. Its established healthcare infrastructure, presence of major medical device manufacturers, and demand for advanced vascular access solutions contribute to its leading position. The region's hospitals and specialised treatment centres also support the use of PICC devices across oncology, critical care, and other clinical applications.

Developing healthcare markets, including China, India, South Africa, and Indonesia, present further opportunities as healthcare infrastructure expands and access to specialised treatment develops. Growing investment in hospitals and diagnostic and treatment facilities may support demand for vascular access products. However, market development will also depend on affordability, product availability, regulatory requirements, and the availability of trained clinical professionals.

Competitive Landscape and Innovation

The competitive environment includes B. Braun Melsungen AG, Cardinal Health, BD, Teleflex Incorporated, Argon Medical Devices, Cook Group, ICU Medical, Medical Components, Access Vascular, Vygon, Meditech Devices, Biowy Corporation, Polymedicure, Footprint Medical, and INSUNG MEDICAL.

Companies compete through product development, catheter materials, design options, distribution networks, and clinical support. Innovation aimed at improving catheter performance and addressing complications is an important area of development. Nevertheless, PICC use can involve risks such as infection, blood clots, catheter blockage, and mechanical complications. The US Centers for Disease Control and Prevention provides guidance on preventing intravascular catheter-related infections, underlining the importance of trained personnel and appropriate maintenance practices.

Outlook

The Global PICC Devices Market is projected to reach USD 1.61 billion by 2030, supported by demand for long-term vascular access and the management of complex medical conditions. Triple-lumen designs and hospital applications currently hold leading positions, while North America remains the largest regional market. Product innovation, healthcare infrastructure development, and stronger attention to catheter safety are expected to influence the industry's direction. Manufacturers that prioritise product quality, clinical suitability, regulatory compliance, and dependable support services will remain important participants in this evolving medical device sector.